Vigencell 바이젠셀
ViGenCell is a KOSDAQ-listed company specialized in immune cell therapy. Immune cell therapy technology of ViGenCell was confirmed to be clinically efficacious through leading basic research at the Catholic University of Korea, College of Medicine. Based on this core technology, the company were established in February 2013 as the first subsidiary of Catholic University Technology Holdings.[Platform Technologies]- ViTier ™(VT): Antigen-specific killer T cell therapy - ViMedier ™(VM): Cord blood-derived myeloid Supressor cell therapy - ViRanger ™(VR): “Off-the-Shelf” Allogenic Universal T cell gene therapy Please copy & paste below link to the address bar to learn more about the pipeline and other details of ViGenCell. https://bit.ly/3cgKi2g. 1 2013 2 VC, 2021 8. T '(ViTier™)',(CBMS)'(ViMedier™)', T '(ViRanger™)'.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
14
51 to 200 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Vigencell 바이젠셀
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Vigencell 바이젠셀
4 distinct titles indexed · top 4 shown.
- 1assistant manager
- 1lead researcher
- 1vigencell(바이젠셀)
- 1대리
Sign up to unlock all 4 contacts at Vigencell 바이젠셀
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Vigencell 바이젠셀
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.